CoC Brief
Jan. 8, 2014

Inflammation in biopsies may indicate lower prostate cancer risk
Urology Times
Signs of inflammation in a man’s prostate biopsy may indicate that he has a reduced risk of subsequently being diagnosed with prostate cancer in a future biopsy, according to the authors of a recently published study. The study’s investigators say that because of its predictive value, inflammation should be routinely reported in prostate biopsies. The association between inflammation and prostate cancer remains controversial. Some studies suggest that anti-inflammatory therapies reduce prostate cancer risk, while others have found that prostate inflammation is linked with a lower risk of cancer.More

Lung cancer screening with CT scans urged for heavy smokers
The Boston Globe
Many heavy smokers and ex-smokers who recently quit should be screened annually for lung cancer with a computed tomography (CT) scan that uses a low dose of radiation, a national panel of prevention experts said recently. Some of these people now get routine chest X-rays, but the panel concluded that CT scans are better able to detect the tiniest lung cancers at an early, more curable stage. Current cigarette smokers ages 55 to 80 who have smoked the equivalent of a pack a day for 30 years or people who had those same smoking habits within the past 15 years should be screened, advised the U.S. Preventive Services Task Force, a group created by Congress.More

Accreditation 101: Learning the Basics of CoC Accreditation and Standards
Commission on Cancer
Are you a new staff member just learning the ropes of CoC accreditation?
Is your cancer program considering CoC accreditation and you want to learn about the CoC standards?
Do you need a basic refresher on the CoC accreditation process and standards?

If you answered yes to any of these questions, then plan to attend Accreditation 101: Learning the Basics of CoC Accreditation and Standards in Austin, Texas, on Feb. 28, 2014. This is the only program developed and taught by CoC surveyors and staff who review the CoC Standards, provide practical information on how to achieve compliance, and discuss the important role you and your cancer team play throughout the continuum of cancer care. Get the information you need from the people involved in standard development and the survey process. For additional information, go to More

Tests of low-risk HPV types fail to detect later cancer risk
Testing for low-risk human papillomavirus (HPV) types should be excluded from cervical cancer screening because such tests fail to predict risk of developing cervical intraepithelial neoplasia (CIN) grade 3 or worse, as well as expose women to potential harm; in addition, they have no proven benefit for patients, according to two large studies. Both reports were published in the January 2014 issue of Obstetrics & Gynecology.More

Exercise improves drug-associated joint pain in breast cancer survivors
Oncology Nurse Advisor
Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercised while on treatment. These results were presented at the 2013 San Antonio Breast Cancer Symposium, Dec. 10-14, 2013. Five years of AI use after surgery or other primary treatment is recommended for postmenopausal women diagnosed with stages 1 to 3 hormone receptor-positive breast cancers, which account for nearly 70 percent of all newly diagnosed breast cancer cases. More

Changing immunosuppressants after transplant may reduce cancer risk
By Joy Burgess
Recent research has shown that the risk of cancer is much higher for individuals dealing with chronic kidney disease. While other studies have shown similar findings, this new research shows that patients with chronic kidney disease are also more likely to die from cancers — specifically, urinary tract cancer and breast cancer. Unfortunately, transplant researchers and physicians feel that immunosuppressant medications may be the cause of the increased risk of cancer.More

Clinicians who would prefer hospice for themselves are more likely to discuss it with patients
Oncology Nurse Advisor
Although the vast majority of physicians participating in a multiregional study indicated that they would personally enroll in hospice care if they received a terminal cancer diagnosis, less than one-third would discuss hospice care early in the course of treating a terminally ill patient with cancer. Recent research also identified factors that increased the likelihood that clinicians would choose hospice care for themselves and examines how their preferences relate to the timing of end-of-life care discussions with patients.More

National Cancer Data Base (NCDB) Call for Data
CoC Source
The official NCDB Call for Data announcement was sent to all programs in a special CoC Source on Oct. 15. The final date for initial submissions is Jan. 31 (midnight Central time), and corrections are due April 1 (midnight Central time). Click "read more" to view the data items required and layout specifications.More

Induction chemotherapy fails in tongue cancer
Induction chemotherapy (IC) is significantly inferior to primary surgery in patients with advanced tongue cancer, according to a comparative study published online Dec. 26, 2013, in JAMA Otolaryngology — Head and Neck Surgery. Referencing his team's failure as "complete" and "spectacular," lead investigator Dr. Douglas Chepeha from the University of Michigan Comprehensive Cancer Center in Ann Arbor told Medscape Medical News that patients should seek a good reconstructive team and undergo surgery to boost their chances of survival.More

Researcher explores link between flame retardants and thyroid cancer
Medical Xpress
Flame retardants are everywhere around us. Governments require manufacturers to put these chemicals into our rugs, cars, furniture, curtains, mattresses and pillows, and even many items of apparel, especially for infants. It's hard to name an item that doesn't contain them. They're in cell phones and computers, stereos and televisions, coffee makers and microwaves. They are supposed to keep us safe by preventing products from bursting into flame and causing dangerous fires. But evidence is mounting that this prevention carries unforeseen costs for human health. More